amagu creates more efficiency and cost reduction in Mobility Management - for small and medium-sized businesses as well as for enterprise. After ENECA has accompanied amagu in development for 3 years, the strategic marketing has been transferred completel
Transcatheter Technologies GmbH, a medical device company that has developed a full range of transcatheter valve implantation systems for catheter-based heart valve therapy, announced today that it has sold its technology portfolio to Venus Medtech. The Transcatheter Technologies’ technology will be the basis of a next-generation product portfolio developed and marketed by Venus Medtech for the Chinese and international markets. Tom Zeller, director and shareholder of ENECA GmbH , invested in 2009 as a business angel in the company and escorted it to the exit .